Mankind Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has closed its trading window for designated persons and their immediate relatives starting July 1, 2025, in line with SEBI's Prohibition of Insider Trading Regulations. The window will remain shut until 48 hours after the company declares its unaudited standalone and consolidated financial results for the quarter ending June 30, 2025 (Q1 FY26). The date of the board meeting to approve these results will be announced separately. The communication was signed by Hitesh Kumar Jain, Company Secretary and Compliance Officer.
This is a routine compliance filing and does not directly affect shareholders. However, it signals that the company is preparing to announce its Q1 FY26 earnings soon, which could be a catalyst for stock movement depending on the results.